Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 

Newsletter April 2018

genetherapynetbanner468x60
News: 13-Year-Old Boy Is First Person in US to Receive Newly Approved Gene Therapy for Blindness
On Tuesday, a 13-year-old boy from New Jersey was at the center of medical history as he became the first person in the US to receive an FDA-approved gene therapy for an inherited disease. The event marks the beginning of a new era of medicine, one in which devastating genetic conditions that we are born with can be simply edited out of our DNA with the help of modern biomedical technologies. The therapy, Luxturna, from Spark Therepeutics, was approved by the FDA in December to treat a rare, inherited form of blindness. Its price tag, set at $850,000—or $425,000 per eye—made it the most expensive drug in the US and sparked mass sticker-shock. But the therapy, which in high-profile clinical trials has allowed patients to see the stars for the first times, also offered the almost miraculous possibility of giving sight to the blind.
Read more...

Conference: 8th Monolith Summer School and Symposium
MSS2018 is a must-attend event for scientists involved in biopharmaceutical process development and Process Analytical Technology (PAT), especially in the fields of plasmids, viruses, and exosomes. Attend lectures by globally recognized researchers and monolith experts, and participate in our cutting-edge workshops.
Space is limited — so please be sure to register early. Register online or contact This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.

Register now...

Company: American Gene Technologies
American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. The company expects its lead candidate for an HIV cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers that is expected to enter trials soon after.
Read more...

Conferences
- 25-26 April 2018, Global Experts Meeting on Cell and Gene Therapy, Dubai, UAE
- 27 April 2018, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), Cardiff, Wales, UK
- 30 April - 2 May 2018, Gene Therapy for Rare Disorders Summit, Boston, MA
- 2 - 5 May 2018, International Society for Cellular Therapy (ISCT) Annual Meeting, Montreal, Canada
- 10 - 11 May 2018, 2nd Annual Genome Editing USA Congress, Boston, MA
- 16 - 19 May 2018, American Society of Gene and Cell Therapy (ASGCT) 21th Annual Meeting, Chicago, IL
- 15 - 20 June 2018, Monolith Summer School and Symposium (MSS) - Bioprocessing of macromolecules and viruses, Portorož, Slovenia
- 18 - 19 June 2018, International conference on Stem Cells and Regenerative Medicine - Genome editing for targeting genetic diseases, Osaka, Japan
- 27 - 28 June 2018, CAR-TCR Summit Asia, Singapore
- 23 - 24 July 2018, Annual Congress on Advanced Tissue Science and Regenerative Medicine, Rome, Italy
- 26 - 28 July 2018, The 24th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 13 - 17 August 2018, Bioprocessing Summit 2018 - Gene Therapy, Boston, MA
- 10 - 11 September 2018, International Conference on Cell and Gene Therapy, Dublin, Ireland
- 16 – 19 October 2018, XXVI Congress of the European Society of Gene and Cell Therapy (ESGCT), Lausanne, Swizterland
- 24 – 25 October 2018, Annual Congress on CRISPR-Cas9 Technology, Boston, MA
- 25 – 26 October 2018, 4th Annual Cell & Gene Therapy Congress, London, UK
- 6-8 November 2018, World Orphan Drug Congress 2018, Barcelona, Spain
- 9-10 November 2018, 2nd Annual Summit on Cell Therapy and Stem Cell Research 2018 Conference, Atlanta, GA
- 23 November 2018, British Society for Gene and Cell Therapy (BSGCT) Annual Conference Autumn 2018, London, UK
- November 2018, 4th Annual Genome Editing UK Congress, London, UK
- 29 April - 2 May 2019, American Society of Gene and Cell Therapy (ASGCT) 22th Annual Meeting, Washington, DC
- 28 – 31 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?